Claudia has more than 20 years of experience in the field of corporate finance, capital markets and M&A.
Claudia currently serves as Chief Financial Officer at VectivBio Group, a spin-off of Therachon (a company acquired by Pfizer in 2019). Previously she acted as General Manager at TiGenix (acquired byTakeda). Prior to this appointment, Claudia was Chief Financial Officer of TiGenix (since May 2011) and led the Company’s IPO on Nasdaq in 2016 as a member of the Executive Committee and as lead for Finance, Legal and Investor Relations. She also served as the Chief Financial Officer of Cellerix and led its merger with TiGenix.
Before joining Cellerix in 2004, Claudia was finance director of Aquanima (Santander Group). Previous experience also includes roles at Deloitte & Touche in Milan, and Apax Partners in Madrid.
Claudia holds a Bachelor’s degree in Economics and a PhD in Business Administration and Finance from Bocconi University.
Claudia serves as Board Observer of CVRx.